Présentations d'affiches
Mon statut pour la session
Sous sessions
Author’s Name(s): Ahmed Abdelaal, Ticiana De Francesco, Ingeborg Stalmans, Francesco Oddone, Markus Lenzhofer, Herbert Reitsamer, Antonio Fea, David Yan, Moulin-Romsee Marie-Isaline, Iqbal (Ike) Ahmed Author’s Disclosure Block: Ahmed Abdelaal: none; Ticiana De Francesco: none; Ingeborg Stalmans: none; Francesco Oddone: none; Markus Lenzhofer: none; Herbert Reitsamer: none; Antonio Fea: none; David Yan: none; Moulin-Romsee Marie-Isaline: none; Iqba...
Author’s Name(s): Emma Youhnovska, Mai Katbe, Wissam B. Nassrallah, Andre Pollmann, Fady Sedarous, Rayan Tolba, Dominique Geoffrion, Mona Harissi-Dagher Author’s Disclosure Block: Emma Youhnovska, none; Mai Katbe, none; Wissam B. Nassrallah, none; Andre Pollmann, none; Fady Sedarous, none; Rayan Tolba, none; Dominique Geoffrion, none; Mona Harissi-Dagher, none Abstract Body Purpose: The Boston Type I Kerato...
Author’s Name(s): Dominique Geoffrion, Joseph Hakim, Younes Agoumi, Mona Harissi-Dagher Author’s Disclosure Block: Dominique Geoffrion, OpenAI Employment/honoraria/consulting fees , OpenAI, Employment/honoraria/consulting fees; Joseph Hakim, none; Younes Agoumi, none; Mona Harissi-Dagher, none Abstract Body Purpose: Glaucoma is the most important vision-threatening complication after Boston keratopros...
Author’s Name(s): Matthaeus Ware, Marko Popovic, Brian BalliosAuthor’s Disclosure Block: Matthaeus Ware: none; Marko Popovic: Grants: Fighting Blindness Canada, DSI Institute, University of Toronto, PSI Foundation; Brian Ballios: Advisory Boards and Consultancy: Bayer, Apellis, F. Hoffmann-La Roche, GelMEDIX, Novartis, Biocon, Endogena Therapeutics - Funded Grants: Foundation Fighting Blindness U.S., Usher1F Collaborative Canada, Ganz Family Foundation...